SEARCH

SEARCH BY CITATION

References

  • 1
    Crowe J, Christensen E, Doniach D, Popper H, Tygstrup N, Williams R. Early features of primary biliary cirrhosis: an analysis of 85 patients. Am J Gastroenterol 1985; 80: 4668.
  • 2
    Schoenfield LI, Christensen E, Doniach D, Popper H, Tygstrup N, Williams R. Bile acids in the skin of patients with pruritic hepatobiliary disease. Nature 1967; 213: 4668.
  • 3
    Ghent CN, Bloomer JR, Klatskin G. Elevations in skin tissue levels of bile acids in human cholestasis: relation to serum levels and to pruritus. Gastroenterology 1977; 73: 112530.
  • 4
    Varadi DP. Pruritus induced by crude bile and purified bile acids. Experimental production of pruritus in human skin. Arch Dermatol 1974; 109: 67881.
  • 5
    Walt RP. Effect of stanozolol on itching in primary biliary cirrhosis. Br Med J 1988; 290: 607.
  • 6
    Stander S, Steinhoff M, Schmelz M, Weisshaar E, Metze D, Luger T. Neurophysiology of pruritus: cutaneous elicitation of itch. Arch Dermatol 2003; 139: 146370.
  • 7
    Thornton JR, Losowsky MS. Opioid peptides and primary biliary cirrhosis. BMJ 1988; 297: 15014.
  • 8
    Bergasa NV, Alling DW, Talbot TL, et al. Effects of naloxone infusions in patients with the pruritus of cholestasis. A double-blind, randomized, controlled trial. Ann Intern Med 1995; 123: 1617.
  • 9
    Bergasa NV, Alling DW, Talbot TL, Wells MC, Jones EA. Oral nalmefene therapy reduces scratching activity due to the pruritus of cholestasis: a controlled study. J Am Acad Dermatol 1999; 41: 4314.
  • 10
    Woolf GM, Reynolds TB. Failure of rifampin to relieve pruritus in chronic liver disease. J Clin Gastroenterol 1990; 12: 1747.
  • 11
    Bachs L, Pares A, Elena M, Piera C, Rodes J. Effects of long-term rifampicin administration in primary biliary cirrhosis. Gastroenterology 1992; 102: 207780.
  • 12
    Podesta A, Lopez P, Terg R, et al. Treatment of pruritus of primary biliary cirrhosis with rifampin. Dig Dis Sci 1991; 36: 21620.
  • 13
    Ghent CN, Carruthers SG. Treatment of pruritus in primary biliary cirrhosis with rifampin. Results of a double-blind, crossover, randomized trial. Gastroenterology 1988; 94: 48893.
  • 14
    Bloomer JR, Boyer JL. Phenobarbital effects in cholestatic liver diseases. Ann Intern Med 1975; 82: 3107.
  • 15
    Browning J, Combes B, Mayo MJ. Long-term efficacy of sertraline as a treatment for cholestatic pruritus in patients with primary biliary cirrhosis. Am J Gastroenterol 2003; 98: 273641.
    Direct Link:
  • 16
    Yosipovitch G, Greaves MW, Schmelz M. Itch. Lancet 2003; 361: 6904.
  • 17
    Krajnik M, Zylicz Z. Understanding pruritus in systemic disease. J Pain Symptom Manage 2001; 21: 15168.
  • 18
    Arthur RP, Shelley WB. The innervation of human epidermis. J Invest Dermatol 1959; 32: 397411.
  • 19
    Mela M, Mancuso A, Burroughs AK. Review article: Pruritus in cholestatic and other liver diseases. Aliment Pharmacol Ther 2003; 17: 85770.
  • 20
    Richardson BP. Serotonin and nociception. Ann N Y Acad Sci 1990; 600: 5119; discussion 519–20.
  • 21
    Richardson BP, Engel G, Donatsch P, Stadler PA. Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs. Nature 1985; 316: 12631.
  • 22
    Schworer H, Ramadori G. Improvement of cholestatic pruritus by ondansetron. Lancet 1993; 341: 1277.
  • 23
    Schworer H, Ramadori G. Treatment of pruritus: a new indication for serotonin type 3 receptor antagonists. Clin Investig 1993; 71: 65962.
  • 24
    Raderer M, Muller C, Scheithauer W. Ondansetron for pruritus due to cholestasis. N Engl J Med 1994; 330: 1540.
  • 25
    Schworer H, Hartmann H, Ramadori G. Relief of cholestatic pruritus by a novel class of drugs: 5-hydroxytryptamine type 3 (5-HT3) receptor antagonists: effectiveness of ondansetron. Pain 1995; 61: 337.
  • 26
    Muller C, Pongratz S, Pidlich J, et al. Treatment of pruritus in chronic liver disease with the 5-hydroxytryptamine receptor type 3 antagonist ondansetron: a randomized, placebo-controlled, double-blind cross-over trial. Eur J Gastroenterol Hepatol 1998; 10: 86570.
  • 27
    Talbot TL, Schmitt JM, Bergasa NV, Jones EA, Walker EC. Application of piezo film technology for the quantitative assessment of pruritus. Biomed Instrum Technol 1991; 25: 4003.
  • 28
    McCormack HM, Horne DJ, Sheather S. Clinical applications of visual analogue scales: a critical review. Psychol Med 1988; 18: 100719.
  • 29
    Blackwell CP, Harding SM. The clinical pharmacology of ondansetron. Eur J Cancer Clin Oncol 1989; 25 (Suppl. 1): 214.